Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
835M
-
Number of holders
-
163
-
Total 13F shares, excl. options
-
25.5M
-
Shares change
-
+918K
-
Total reported value, excl. options
-
$1.28B
-
Value change
-
+$45.9M
-
Number of buys
-
79
-
Number of sells
-
-61
-
Price
-
$50.45
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q4 2014
176 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q4 2014.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 163 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.5M shares
of 835M outstanding shares and own 3.05% of the company stock.
Largest 10 shareholders include Fisher Asset Management, LLC (4.15M shares), COMMONWEALTH BANK OF AUSTRALIA (2.43M shares), BlackRock Group LTD (1.55M shares), AQR CAPITAL MANAGEMENT LLC (1.4M shares), VANGUARD GROUP INC (1.38M shares), SCHRODER INVESTMENT MANAGEMENT GROUP (1.29M shares), Sectoral Asset Management Inc (763K shares), FIL Ltd (748K shares), JPMORGAN CHASE & CO (724K shares), and CAUSEWAY CAPITAL MANAGEMENT LLC (603K shares).
This table shows the top 163 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.